A closer look at the returns and risks of pharmaceutical R&D-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A closer look at the returns and risks of pharmaceutical R&D

Published:1986-06 Issue:2 Volume:5 Page:153-177
ISSN:0167-6296
Container-title:Journal of Health Economics
language:en
Short-container-title:Journal of Health Economics

Author:

Joglekar Prafulla,Paterson Morton L.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference33 articles.

1. Profit rates and economic performance of drug firms;Ayanian;Relative profitability and monopoly power,1972

2. Research and development costs and returns: The U.S. pharmaceutical industry;Baily;Journal of Political Economy,1972

3. Barriers to new competition;Bain,1956

4. Economics of the pharmaceutical industry;Blee,1978

5. Comments at AEI symposium;Blee,1978

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to Combat Multidrug Resistance by Non-traditional Therapeutic Approaches;Non-traditional Approaches to Combat Antimicrobial Drug Resistance;2023

2. Dividend policy issues in the European pharmaceutical industry: new empirical evidence;The European Journal of Health Economics;2022-08-26

3. Project, Risk, and Portfolio Management – Managing R & D Projects Today*;Principles of Biomedical Sciences and Industry;2022-07-22

4. Returns on different types of investment in the global pharmaceutical industry;Managerial and Decision Economics;2018-10-18

5. A Review of the Pharmaceutical R&D Efficiency: Costs, Timelines, and Probabilities;Value Creation in the Pharmaceutical Industry;2016-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP